Histological, mucin histochemical and immunohistochemical study of Barrett's epithelium and adenocarcinoma

Stomach and Intestine

Volumn 34, Issue 2, 1999, Pages 151-153

  Tajima, Yusuke ^a,b   Shimoda, Tadakazu ^a   Nakanishi, Yukihiro ^c   Ikegami, Masahiro ^d   Kusano, Alitsuo ^b  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0004409429     PISSN: 05362180     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 315: 362-371, 1986
2. Skinner M, Walther BC, Little AG. Surgical treatment of Barrett's esophagus. In Spechler SJ, Goyal RK (eds). Barrett's esophagus, Pathophysiology, Diagnosis, and Management, Elsevier Sci Publ Co, New York, pp 211-221, 1985
3. Bremner CG, Hamilton DG. Barrett's esophagus : Controversial aspects. In De Meester TR, Skinner DB (eds). Esophageal Disorders, Pathophysiology and Therapy, Raven Press, New York, pp 233-239, 1985
4. Reid BJ, Weinstein WF. Barrett's esophagus and adenocarcinoma. Annu Rev Med 38: 477-492, 1987
5. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 60: 1094-1098, 1987
6. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hun Pathol 19: 942-948, 1988
7. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104: 510-513, 1993
8. Yang PC, Davis S. Incidence of cancer of the esophagus in US by histologic type. Cancer 61: 612-617, 1988
9. Farrow DC, Vaughan TL. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States). Cancer Causes and Control 7: 322-327, 1996
10. Thompson JJ, Zinsser KR, Enterline HT. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 14: 43, 1985
11. Hameeteman W, Tytgat GNJ, Houthoff HJ, et al. Barrett's esophagus, development of dysplasia and adenocarcinoma. Gastroenterology 96: 1249, 1989
12. Edwards MJ, Gable DR, Lentsch AB, et al. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 223: 585-589, 1996
13. Riddel RH. Dysplasia and regression in Barrett's epithelium. In Spechler SJ, Goyal RK (eds). Barrett's Esophagus, Pathophysiology, Diagnosis, and Management. Elsevier Sci Publ Co, New York, pp 145-152, 1985
14. Tytgat GNJ, Hameeteman W. The neoplastic potential of columnar-lined (Barrett's) esophagus. World J Surg 16: 308-312, 1992
15. Schlemper RJ, Itabashi M, Kato Y, et al. Differences in the diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 349: 1725-1729, 1997
16. Schlemper RJ, Itabashi M, Kato Y, et al. Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer 82: 60-69, 1998
17. Paull A, Trier JS, Dalton D, et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 259: 476-480, 1976
18. Peuchmaur M, Potet F, Goldfain D: Mucin histochemistry of the columnar epithelium of the oesophagus (Barrett's esophagus); a prospective biopsy study. J Clin Pathol 37: 607-610, 1984
19. Lee RG. Mucins in Barrett's esophagus : A histochemical study. Am J Clin Pathol 81: 500-503, 1984
20. Offner FA, Lewin KJ, Weinstein WM. Metaplastic columnar cells in Barrett's esophagus ; a common and neglected cell type. Hum Pathol 27: 885-889, 1996
21. goblet cell metaplasia. 17: 1029-1034, 1982
22. Hirota T, Okada M, Itabashi M, et al. Significance of intestinal metaplasia as a precancerous condition of the stomach. In Ming, SC (ed). Precursors of the gastric cancer, Praeger, New York, pp 179-183, 1984
23. Inada K, Nakanishi H, Fujimitsu Y, et al. Gastric and intestinal mixed and solely intestinal types of intestinal metaplasia in the human stomach. Pathol International 47: 831-841, 1997
24. Ridclell RH, Goldman H, Ransohoff DF. Dysplasia in inflammatory bowel disease ; standardized classification with provisional clinical applications. Hum Pathol 14: 931-968, 1983
25. Reid BJ, Weinstein WM, Lewin KJ, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic leisions. Gastroenterology 94: 81-90, 1988
26. Lauren P. The two histological main types of gastric carcinoma : Diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand (A) 64: 31-49, 1965
27. Kushima R, Hattori T. Histogenesis and characteristics of gasric type adenocarcinoma. J Cancer Res Clin Oncol 120: 103-111, 1993
28. Tatematsu M, Hasegawa R, Ogawa K, et al. Histogenesis of human stomach cancers based on assessment of differentiation. J Clin Gastroenterol 14 suppl. : S1-7, 1992
29. Hong MK, Laslin WB, Herman BE, et al. Expansion of the Ki- 67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 75: 423-429, 1995
30. Polkowski W, van Lanschot JJ, Ten Kate FJ, et al. The value of p53 and Ki-67 as markers for tumor progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol 4: 163-171, 1995
31. Krishnadath KK, Tilanus HW, Blankenstein MV, et al. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 175: 175-180, 1995
32. Ochiai A, Yamauchi U, Hirohashi S. p53 Mutation in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer 69: 28-33, 1996